Development of CRISRP/Cas9-based TP53-knockout pig muscle stem cells for use in the cultured meat industry

开发基于CRISRP/Cas9的TP53敲除猪肌肉干细胞用于人造肉行业

阅读:10
作者:Witsanu Srila ,Amorn Pangjantuk ,Phongsakorn Kunhorm ,Nipha Chaicharoenaudomrung ,Parinya Noisa

Abstract

Muscle satellite cells (MSCs) are essential for cultured meat production although their restricted lifespan and diminished stemness during prolonged culture pose significant limitations. This study established immortalized porcine MSCs using TP53 gene deletion with the CRISPR/Cas9 technology. Several TP53-knockout (KO) clones were generated, exhibiting indel alterations and monoallelic and biallelic deletions. These clones exhibited markedly prolonged cellular lifespans compared to wild-type cells, overcoming the constraints of senescence. The growth rates and the proliferation marker (ki67) gene expression (passage 20) in the TP53-KO clones were dramatically elevated compared to the WT cells. All TP53-KO clones demonstrated a loss of stemness, proliferation, and muscle differentiation marker gene expression during long-term cell culture except for Desmin expression in the TP53-KO 42 clone. Immortalized TP53-KO clones maintained the ability to express muscle-specific protein markers compared to wild-type cells. Moreover, all clones had non-tumorigenic behavior, except TP53-KO clones 41 and 42, which displayed tumorigenic potential. TP53-KO clones demonstrated enhanced myogenic differentiation efficiency after multiple passages in comparison to wild-type cells. The results highlight the potential of TP53-KO MSCs as a cellular resource for future cultured meat production. Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04225-5. Keywords: CRISPR/Cas9; Cellular immortalization; Cultured meat; Muscle satellite cells; Tumor protein 53.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。